Laboratorio Pablo Cassara S.R.L.
2 clinical trials · Sponsor
◉ Watch Laboratorio Pablo Cassara S.R.L.
| Record | Firm | Date |
|---|---|---|
| ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine (NCT05656508) | Laboratorio Pablo Cassara S.R.L. | 2022-04-20 |
Track Laboratorio Pablo Cassara S.R.L. automatically
Every clearance here is in the API, with alerts when new ones post.